The Use of Dapsone as a Novel “Persister” Drug in the Treatment of Chronic L yme Disease/Post Treatment Lyme Disease

This document was uploaded by one of our users. The uploader already confirmed that they had the permission to publish it. If you are author/publisher or own the copyright of this documents, please report to us by using this DMCA report form.

Simply click on the Download Book button.

Yes, Book downloads on Ebookily are 100% Free.

Sometimes the book is free on Amazon As well, so go ahead and hit "Search on Amazon"

We tested the efficacy of DDS in patients with chronic Lyme disease/PTLDS with tick-borne co-infections including Babesiosis, who failed commonly used antibiotic and antimalarial protocols.

Author(s): Maryalice Citera, Phyllis R Freeman, Richard I Horowitz
Series: Volume 7, Issue 3, 1000345
Edition: Volume 7
Publisher: Journal of Clinical & Experimental Dermatology Research
Year: 2016

Language: English
Pages: 7
City: New York
Tags: Dapsone, Lyme, Dapsone, Rifampin, Chronic Lyme disease, Post Treatment Lyme Disease Syndrome (PTLDS), Biofilms, Babesiosis, Tick-borne co-infections, Persister bacteria, Morgellons Syndrome, Multisystemic infectious disease syndrome